| Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01) JS Cooper, MD Guo, A Herskovic, JS Macdonald, JA Martenson Jr, ... Jama 281 (17), 1623-1627, 1999 | 2657 | 1999 |
| Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or … JD Bradley, R Paulus, R Komaki, G Masters, G Blumenschein, S Schild, ... The lancet oncology 16 (2), 187-199, 2015 | 2153 | 2015 |
| Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial ML Gillison, AM Trotti, J Harris, A Eisbruch, PM Harari, DJ Adelstein, ... The Lancet 393 (10166), 40-50, 2019 | 1276 | 2019 |
| Randomized phase III trial of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III to IV head and neck carcinoma: RTOG 0522 KK Ang, Q Zhang, DI Rosenthal, PF Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of clinical oncology 32 (27), 2940-2950, 2014 | 901 | 2014 |
| Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck … R Haddad, A O'Neill, G Rabinowits, R Tishler, F Khuri, D Adkins, J Clark, ... The lancet oncology 14 (3), 257-264, 2013 | 809 | 2013 |
| Detection of circulating tumor cells in human peripheral blood using surface-enhanced Raman scattering nanoparticles X Wang, X Qian, JJ Beitler, ZG Chen, FR Khuri, MM Lewis, HJC Shin, ... Cancer research 71 (5), 1526-1532, 2011 | 425 | 2011 |
| Treatment of late sequelae after radiotherapy for head and neck cancer P Strojan, KA Hutcheson, A Eisbruch, JJ Beitler, JA Langendijk, AWM Lee, ... Cancer treatment reviews 59, 79-92, 2017 | 388 | 2017 |
| Adenoid cystic carcinoma of the head and neck: incidence and survival trends based on 1973‐2007 surveillance, epidemiology, and end results data CL Ellington, M Goodman, SA Kono, W Grist, T Wadsworth, AY Chen, ... Cancer 118 (18), 4444-4451, 2012 | 374 | 2012 |
| Current trends in initial management of laryngeal cancer: the declining use of open surgery CE Silver, JJ Beitler, AR Shaha, A Rinaldo, A Ferlito European Archives of Oto-Rhino-Laryngology 266, 1333-1352, 2009 | 347 | 2009 |
| Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets A Eisbruch, RL Foote, B O'Sullivan, JJ Beitler, B Vikram Seminars in radiation oncology 12 (3), 238-249, 2002 | 277 | 2002 |
| Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer JJ Beitler, Q Zhang, KK Fu, A Trotti, SA Spencer, CU Jones, AS Garden, ... International Journal of Radiation Oncology* Biology* Physics 89 (1), 13-20, 2014 | 255 | 2014 |
| Practice recommendations for risk-adapted head and neck cancer radiation therapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement DJ Thomson, D Palma, M Guckenberger, P Balermpas, JJ Beitler, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 618-627, 2020 | 241 | 2020 |
| Ultrasound GLCM texture analysis of radiation‐induced parotid‐gland injury in head‐and‐neck cancer radiotherapy: An in vivo study of late toxicity X Yang, S Tridandapani, JJ Beitler, DS Yu, EJ Yoshida, WJ Curran, T Liu Medical physics 39 (9), 5732-5739, 2012 | 235 | 2012 |
| Long-term swallowing problems after organ preservation therapy with concomitant radiation therapy and intravenous hydroxyurea: initial results RV Smith, T Kotz, JJ Beitler, S Wadler Archives of Otolaryngology–Head & Neck Surgery 126 (3), 384-389, 2000 | 232 | 2000 |
| Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009 B Ansa, M Goodman, K Ward, SA Kono, TK Owonikoko, K Higgins, ... Cancer 119 (14), 2602-2610, 2013 | 230 | 2013 |
| Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas DJ Lee, D Cosmatos, VA Marcial, KK Fu, M Rotman, JS Cooper, HG Ortiz, ... International Journal of Radiation Oncology* Biology* Physics 32 (3), 567-576, 1995 | 219 | 1995 |
| Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review P Strojan, JB Vermorken, JJ Beitler, NF Saba, M Haigentz Jr, P Bossi, ... Head & neck 38 (S1), E2151-E2158, 2016 | 216 | 2016 |
| A randomized phase III trial (RTOG 0522) of concurrent accelerated radiation plus cisplatin with or without cetuximab for stage III-IV head and neck squamous cell carcinomas (HNC). KK Ang, QE Zhang, DI Rosenthal, P Nguyen-Tan, EJ Sherman, RS Weber, ... Journal of Clinical Oncology 29 (15_suppl), 5500-5500, 2011 | 213 | 2011 |
| Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy. DP Kelsen, B Minsky, M Smith, J Beitler, D Niedzwiecki, D Chapman, ... Journal of Clinical Oncology 8 (8), 1352-1361, 1990 | 184 | 1990 |
| Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate P Strojan, J Corry, A Eisbruch, JB Vermorken, WM Mendenhall, AWM Lee, ... Head & neck 37 (1), 134-150, 2015 | 164 | 2015 |
